Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes - PubMed (original) (raw)
Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes
S Norris et al. J Hepatol. 1998 Jan.
Abstract
Background/aims: Murine and human studies have documented the existence of subpopulations of lymphocytes in particular tissues that differ phenotypically and functionally from those in peripheral blood and may mature locally. Since little is known about lymphocyte subpopulations in the normal human liver, we have analysed the surface phenotypes of lymphocytes isolated from liver specimens taken from 15 donors at the time of liver transplantation, and compared these with those of peripheral blood lymphocytes.
Methods: Hepatic lymphocytes were prepared by mechanical dissociation and enzymatic digestion of liver tissue. The cells were stained with a panel of monoclonal antibodies (CD3, CD4, CD8, CD19, CD56, gammadeltaTCR, alphabetaTCR, CD8alpha-chain, CD8alphabeta dimer), and analysed by flow cytometry. In situ characterisation of hepatic lymphocytes was by haematoxylin and eosin staining of fixed liver sections and by immunohistochemical staining for common leukocyte antigen and CD3.
Results: Significant numbers of hepatic T lymphocytes were localised to the portal tracts and parenchyma of normal liver specimens. Flow cytometry revealed that the CD4/CD8 ratio (1:3.5) was consistently reversed compared with that in peripheral blood (2:1). Other lymphocyte populations identified include double positive CD3+CD4+CD8+ cells which accounted for a mean of 5.5% (range 3-11.6%) of hepatic CD3+ cells compared with 1.3% in blood (range 0.7-3.6%; p < 0.007), and double negative CD3+ CD4-8- cells (14.5%; range 2.7-29% compared with 5.0%; range 2.1-10.8%, p < 0.02). Over 15% (range 6.8-34%) of all hepatic CD3+ cells expressed a gammadeltaTCR compared to 2.7% (range 0.9-4.7%) of CD3+ peripheral blood lymphocytes (p < 0.004) and almost 50% of these coexpressed CD8. The CD8 alpha-chain was expressed without the beta-chain (CD8alpha+beta-) by 15.4% (range 4-29.1%) of hepatic T cells, but this phenotype was undetectable among peripheral blood lymphocytes (p < 0.009). Cells expressing both the T cell marker CD3 and the natural killer cell marker CD56 constituted 31.6% (range 14-54%) of all hepatic CD3+ lymphocytes but were rarely present amongst peripheral blood lymphocytes (0-6%; p < 0.0001).
Conclusions: These data are the first to describe and quantify unconventional T lymphocyte subpopulations in the normal adult human liver which may have specialised functions in regional immune responses and which may differentiate locally. These findings have important implications for our understanding of hepatic immunoregulation and the pathogenic mechanisms involved in viral and immune-mediated liver disease and allograft rejection.
Similar articles
- Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M. D'Arena G, et al. Haematologica. 1998 Mar;83(3):197-203. Haematologica. 1998. PMID: 9573672 - Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R, Deeb K, Diamante M, Ashman M, Sachdeva N, Asthana D. Valiathan R, et al. Immunobiology. 2014 Jul;219(7):487-96. doi: 10.1016/j.imbio.2014.02.010. Epub 2014 Mar 2. Immunobiology. 2014. PMID: 24661720 - [Deep lung--cellular reaction to HIV].
Tavares Marques MA, Alves V, Duque V, Botelho MF. Tavares Marques MA, et al. Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese. - Human liver-associated lymphocytes: an overview.
Winnock M, Garcia Barcina M, Lukomska B, Huet S, Saric J, Balabaud C, Bioulac-Sage P. Winnock M, et al. J Gastroenterol Hepatol. 1995;10 Suppl 1:S43-6. doi: 10.1111/j.1440-1746.1995.tb01796.x. J Gastroenterol Hepatol. 1995. PMID: 8589341 Review.
Cited by
- Understanding, predicting and achieving liver transplant tolerance: from bench to bedside.
Thomson AW, Vionnet J, Sanchez-Fueyo A. Thomson AW, et al. Nat Rev Gastroenterol Hepatol. 2020 Dec;17(12):719-739. doi: 10.1038/s41575-020-0334-4. Epub 2020 Aug 5. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32759983 Review. - Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.
Castello G, Costantini S, Scala S. Castello G, et al. J Transl Med. 2010 Nov 3;8:109. doi: 10.1186/1479-5876-8-109. J Transl Med. 2010. PMID: 21047421 Free PMC article. Review. - Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma.
Rennert C, Tauber C, Fehrenbach P, Heim K, Bettinger D, Sogukpinar Ö, Schuch A, Zecher BF, Bengsch B, Lang SA, Bronsert P, Björkström NK, Fichtner-Feigl S, Schultheiss M, Thimme R, Hofmann M. Rennert C, et al. Cells. 2021 Jun 2;10(6):1369. doi: 10.3390/cells10061369. Cells. 2021. PMID: 34199483 Free PMC article. Clinical Trial. - Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity.
Maretti-Mira AC, Salomon MP, Hsu AM, Dara L, Golden-Mason L. Maretti-Mira AC, et al. Front Immunol. 2023 Mar 30;14:1137034. doi: 10.3389/fimmu.2023.1137034. eCollection 2023. Front Immunol. 2023. PMID: 37063898 Free PMC article. - Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.
Yanagisawa K, Yue S, van der Vliet HJ, Wang R, Alatrakchi N, Golden-Mason L, Schuppan D, Koziel MJ, Rosen HR, Exley MA. Yanagisawa K, et al. J Viral Hepat. 2013 Aug;20(8):556-65. doi: 10.1111/jvh.12081. Epub 2013 Mar 11. J Viral Hepat. 2013. PMID: 23808994 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous